Marie Obien is the Chief Commercial Officer (CCO) and a founding member of MaxWell Biosystems. Marie leads the company’s global commercial strategy, sales, business development, marketing, product management, channel partnerships, and customer success. A specialist in electrophysiology, Marie brings strong expertise in microelectrode arrays and complementary techniques, including the gold-standard patch-clamp method. She is the lead author of the most frequently cited review on MEA technology and has played a key role in shaping its adoption in neuroscience and drug discovery. Marie earned her PhD in Electrical Engineering from the Nara Institute of Science and Technology, Japan, and received neuroscience training as a postdoctoral researcher at RIKEN. She also completed the Global Innovation Program in Silicon Valley, focusing on business development and entrepreneurial leadership.

‍